FibroGen Reports First Quarter 2023 Financial Results
• Topline Data From Four Phase 3 Trials Expected Through 3Q 2023 • Completed Non-Dilutive Term Loan Financing for up to $150 Million with Morgan Stanley Tactical Value ... | May 8, 2023
South Africa Eluminex Biosciences Enrique Conterno Meichiel Jennifer Keenan Michael Tung Globenewswire Inc
Source: marketscreener.com